|
|
||||||||||||||
|
|
|||||||||||||||
COMMENTARY |
| Ghrelin |
Correspondence to:
Correspondence to:
Dr P J Hornby
Enterology Biology Team Leader, Johnson & Johnson, Research and Development L L C, UK; phornby@prdus.jnj.com
Keywords: ghrelin; obesity; antagonism; NOX-B11; food intake; rat
| The first 150 words of the full text of this article appear below. |
The article by Kobelt and colleagues1 in this issue of Gut, further explores a novel mechanism to interfere with the action of ghrelin on its receptor, growth hormone secretagogue receptor 1 (GHS-R) (see page 788). Ghrelin is a 28 amino acid peptide localised immunocytochemically in parietal cells of the human stomach2 where it is released and stimulates growth hormone release, food intake, and adiposity. Human plasma has relatively low levels of ghrelin3 although, somewhat counter intuitively, in anorectic patients the fasting level of ghrelin, including the active form (n-octanoyl modification at serine 3), is significantly higher.4 The main impact of this work is that the investigators have demonstrated the efficacy of and dose related inhibition of ghrelin stimulated food intake in rats. They did this by using a biological approach to bind to ghrelin and prevent the interaction of ghrelin with its receptor in
Related Article
Gut 2006 55: 788-792.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |